# The Effect of Efavirenz and Nelfinavir on the Blood Levels of Certain Lipid-Lowering Drugs

> **NCT00017758** · PHASE1 · COMPLETED · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)** · enrollment: 56 (—)

## Conditions studied

- HIV Infections
- HIV Seronegativity
- Lipodystrophy

## Interventions

- **DRUG:** Pravastatin sodium
- **DRUG:** Simvastatin
- **DRUG:** Atorvastatin calcium
- **DRUG:** Nelfinavir mesylate
- **DRUG:** Efavirenz

## Key facts

- **NCT ID:** NCT00017758
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 56 (—)
- **Last updated:** 2006-03-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00017758

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00017758, "The Effect of Efavirenz and Nelfinavir on the Blood Levels of Certain Lipid-Lowering Drugs". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00017758. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*